Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia.

Abstract

Hemorrhagic transformation (HT) is a major factor limiting the use of tissue plasminogen activator (tPA) for stroke patients. This study examined the role of deferoxamine (DFX) in brain injury and HT in a rat model of transient focal ischemia with hyperglycemia. Rats received an injection of 50% glucose (6 mL/kg, i.p.) 15 min before undergoing transient middle cerebral artery occlusion (tMCAO; 2 h occlusion) with reperfusion. Rats were treated with DFX (100 mg/ kg, i.m.) or vehicle immediately after tMCAO. Rats were killed at 4, 8 and 24 h later and used for brain edema, blood-brain barrier permeability, hemorrhage volume, hemoglobin content, and infarct volume measurements. Mortality rate was also evaluated. DFX treatment reduced mortality at 24 h (4% vs. 24% in the vehicle-treated group, p<0.05). DFX also reduced infarct volume (85.1+/-56.3 vs. 164.3+/-93.4 mm(3) in vehicle, p<0.05) and swelling in the basal ganglia (p<0.05) 24 h after tMCAO. The total hemorrhage volume in the ipsilateral hemisphere at 8 h post tMCAO was less in DFX-treated animals (p<0.05). However, blood-brain barrier permeability was same in DFX- and vehicle-treated groups. DFX attenuates death rate, hemorrhagic transformation, infarct volume, and brain swelling in a rat transient focal ischemia with hyperglycemia model, suggesting that DFX could be potential treatment to reduce the hemorrhagic transformation for stroke patients.

• Authors: Yingqi Xing, Ya Hua, Richard F Keep, Guohua Xi
• Journal: Brain research (Brain Res) Vol. 1291 Pg. 113-21 (Sep 29 2009) ISSN: 1872-6240 [Electronic] Netherlands
• PMID: 19631616 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Hemoglobins
• Deferoxamine

Topics

• Animals
• Blood-Brain Barrier (pathology)
• Body Water (chemistry)
• Brain (pathology)
• Brain Chemistry
• Brain Edema (pathology)
• Deferoxamine (therapeutic use)
• Hemoglobins (analysis)
• Hyperglycemia (complications, mortality, pathology)
• Infarction, Middle Cerebral Artery (complications, drug therapy, mortality, pathology)
• Intracranial Hemorrhages (drug therapy, etiology, mortality, pathology)
• Ischemic Attack, Transient (complications, drug therapy, mortality, pathology)
• Male
• Neurologic Examination
• Rats
• Rats, Sprague-Dawley
• Reperfusion Injury (drug therapy, pathology)